6 women die, 10 injure as jeep hits tractor trailer

Mandya, Jan 25: A woman committed suicide by jumping into Vishveshwaraiah Canal after throwing her two children into the canal near Thibbanahalli in the Taluk, police said on Saturday.

The deceased have been identified as Jyothi (33), Nisarga (7) and Pavan (4), of Hullenahalli.

According to police, the incident occurred on Friday.

Bengaluru, May 24: With 130 new cases, Karnataka's COVID-19 tally crossed the 2,000-mark on Sunday. Most new cases reported have interstate travel history with 97 coming from Maharashtra. The number of active cases in the state is 1,391 and the deaths reported so far is 42, including 2 for non-COVID reasons.

"Ninety seven of the 130 new patients are returnees from Maharashtra, the worst affected state in the country with 47,190 cases till Saturday," said a state health official. 

"The total number of COVID-19 cases across the state is 2,089, with 130 more testing positive in the past 18 hours," said the official.

Forty six patients were discharged from hospitals on Sunday taking the number of cured persons to 634. Of the 46 discharged, 18 are in Davanagere, 20 in Uttara Kannada, 4 in Chitradurga, 3 in Bagalakote and one in Haveri.

Of the 30 Karnataka districts, Chikkaballapura recorded the highest cases on Sunday at 27, followed by Yadgir (24), Udupi (23), Mandya (15) and Hassan (14).

Chikkaballapura is the home district of Medical Education Minister K Sudhakar, a doctor by profession, who is spearheading the fight against the pandemic.

On Saturday, the state's tally shot up to 1,959 due to 196 new cases, the highest single-day rise, with 195 of them crossing over from Maharashtra through the inter-state border, which was opened up as part of partial relaxation of the lockdown.  

The Karnataka government has imposed institutional quarantine on persons traveling in from outside the state, particularly by flight from Maharashtra, Gujarat, Tamil Nadu, Delhi, Rajasthan, and Madhya Pradesh.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.